# Wanbury Ltd (WANBURY)
> Exchange: NSE | Sector: Pharma | ISIN: 

## Price
Current Price: ₹283.6
Day Change: +0.05%
52W High: ₹320.95
52W Low: ₹161.5
Market Cap: ₹902 Cr

## Valuation
P/E: 13.48
P/B: 14.27
EPS: ₹19.14
Book Value: ₹18.09
Dividend Yield: 0%

## Returns
1Y Return: 17.86%

## Profitability
ROE: 0%
ROCE: 72.22%
Debt/Equity: 0
Revenue Growth: -19.2%
Profit Growth: 0%
EBITDA Margin: -20%
Operating Margin: 5.49%

## About
Wanbury Ltd is a Drug Manufacturers - Specialty & Generic company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Drug Manufacturers - Specialty & Generic
Sub Industry: Unknown

## Business Model
Overview: Wanbury Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Drug Manufacturers - Specialty & Generic. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Announcement: Update on board meeting
- Quarterly Report: Board Meeting Intimation for Notice Of Board Meeting For Approving The Audited Financial Results & Statements Of The Company For The Fourth Quarter And Year Ended 31St March, 2026.
- BSE Filing: Update on board meeting

## Access
Current tier: anonymous
More history: Register free to see 13 more years.

## Data Freshness
Quote Updated: 2026-05-25T20:00:13.927Z
Price History Updated: 2026-05-25T05:33:19.729Z
Latest Price History Date: 2026-05-24
Technicals Updated: 2026-05-25T05:33:19.729Z
Quant Updated: 2026-05-25T05:33:19.729Z
Sentiment Updated: 2026-05-25T05:33:19.729Z
Financials Status: current
Financials Updated: 2026-05-19T12:30:32.918Z
Financials Last Attempt: 2026-05-19T12:30:32.918Z
Financials Provider Tried: yahoo
Latest P&L Period: FY25
Latest Balance Sheet Period: FY25
Latest Cash Flow Period: FY25

## P&L (FY25)
Revenue: ₹593.54 Cr
Operating Profit: ₹70.25 Cr (OPM 11.84%)
Net Profit: ₹30.53 Cr
Tax: ₹-0.98 Cr

## Annual P&L History
FY25: Rev ₹593.54Cr | PAT ₹30.53Cr | OPM 11.84%
FY24: Rev ₹574.48Cr | PAT ₹55.96Cr | OPM 9.96%
FY23: Rev ₹498.18Cr | PAT ₹-10.4Cr | OPM 2.38%

## Balance Sheet (FY25)
Total Assets: ₹413.92 Cr
Total Liabilities: ₹354.65 Cr
Borrowings: ₹176.91 Cr
Cash: ₹4.06 Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

## Board
- Mohan Kumar Rayana, Whole Time Director
- Vinod R. Verma, Chief Financial Officer
- Jitendra Jayantilal Gandhi, Compliance Officer & Company Secretary
- Shireesh Bhalchandra Ambhaikar, President of Operations - API Business
- Nanasaheb  Gunjal, Senior Vice President of QA,QC & RA

---
Source: rupiya.io/stocks/wanbury
Disclaimer: For research and education only. Not investment advice.